Accrelist Ltd. (SG:QZG) has released an update.
Accrelist Ltd. has announced the strategic acquisition of a 60% equity stake in Accrelist Nanjing, a Chinese health management company, as part of its expansion plans into China’s robust medical aesthetic services market. With this move, Accrelist aims to capitalize on China’s medical aesthetics industry, which is forecasted to grow substantially, driven by economic resilience and a surging consumer demand. The merger is expected to strengthen Accrelist’s market position and create long-term shareholder value through combined expertise and expanded service offerings.
For further insights into SG:QZG stock, check out TipRanks’ Stock Analysis page.
